These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7357058)

  • 21. Effects of clonidine in narcolepsy.
    Salín-Pascual R; de la Fuente JR; Fernández-Guardiola A
    J Clin Psychiatry; 1985 Dec; 46(12):528-31. PubMed ID: 4066618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Memory enhancement in Korsakoff's psychosis by clonidine: further evidence for a noradrenergic deficit.
    McEntee WJ; Mair RG
    Ann Neurol; 1980 May; 7(5):466-70. PubMed ID: 6994586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonidine decreases opiate withdrawal-related anxiety: possible opiate noradrenergic interaction in anxiety and panic.
    Gold MS; Pottash AL; Sweeney DR; Davies RK; Kleber HD
    Subst Alcohol Actions Misuse; 1980; 1(2):239-46. PubMed ID: 7302782
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clonidine for the treatment of heroin withdrawal syndrome].
    Schanda H; Presslich O; Hermann P
    Wien Klin Wochenschr; 1983 Aug; 95(16):569-72. PubMed ID: 6649643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M; Wilkins A; Werstiuk ES; Steiner M
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.
    Reid JL; Wing LM; Dargie HJ; Hamilton CA; Davies DS; Dollery CT
    Lancet; 1977 Jun; 1(8023):1171-4. PubMed ID: 68274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clonidine in opiate withdrawal. II. Potential side-effects].
    Keup W
    MMW Munch Med Wochenschr; 1982 Feb; 124(7):153-5. PubMed ID: 6801495
    [No Abstract]   [Full Text] [Related]  

  • 28. The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.
    Harvey PD; Endicott JM; Loebel AD
    Bipolar Disord; 2008 Dec; 10(8):900-6. PubMed ID: 19594505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonidine treatment of schizophrenia. Double-blind comparison to placebo and neuroleptic drugs.
    Freedman R; Kirch D; Bell J; Adler LE; Pecevich M; Pachtman E; Denver P
    Acta Psychiatr Scand; 1982 Jan; 65(1):35-45. PubMed ID: 6138923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsy Behav; 2007 May; 10(3):449-55. PubMed ID: 17350342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin.
    Boehnlein JK; Kinzie JD
    J Psychiatr Pract; 2007 Mar; 13(2):72-8. PubMed ID: 17414682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of atenolol and clonidine on polygraphically recorded sleep in hypertensive men: a randomized, double-blind, crossover study.
    Danchin N; Genton P; Atlas P; Anconina J; Leclere J; Cherrier F
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):52-5. PubMed ID: 7711993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of beneficial effects of clonidine in the treatment of premenstrual dysphoric disorder: results of a double-blind, randomized study.
    Bunevicius R; Hinderliter AL; Light KC; Pedersen CA; Girdler SS
    Hum Psychopharmacol; 2005 Jan; 20(1):33-9. PubMed ID: 15536640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
    Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Administration of naloxone in schizophrenic psychoses and manic syndromes].
    Verhoeven WM; van Praag HM; de Jong JT
    Ned Tijdschr Geneeskd; 1981 Apr; 125(14):532-7. PubMed ID: 6112715
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of noradrenergic and GABA-ergic inputs in pedunculopontine tegmentum for regulation of rapid eye movement sleep in rats.
    Pal D; Mallick BN
    Neuropharmacology; 2006 Jul; 51(1):1-11. PubMed ID: 16616214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clonidine--potential dependence risk in psychiatric patients?].
    Agelink MW; Dammers S; Zeit T
    Nervenarzt; 1996 Mar; 67(3):253-5. PubMed ID: 8901285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lofexidine in alcohol withdrawal states.
    Brunning J; Mumford JP; Keaney FP
    Alcohol Alcohol; 1986; 21(2):167-70. PubMed ID: 3741551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.